INTERNATIONAL REGULATORY REQUIREMENTS WITH RESPECT TO THE PHARMACEUTICAL ASPECTS OF NEW DRUG DEVELOPMENT

被引：0
|
作者：
SULLMAN, SF
机构：
来源：
PHARMACOPEIAL FORUM | 1984年 / 10卷 / 05期
关键词：
D O I：
暂无
中图分类号：
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号：
0301 ; 10 ;
摘要：
引用
收藏
页码：4611 / 4620
页数：10
相关论文
共 50 条
  • [1] DEVELOPMENT AND REGULATORY ASPECTS OF NEW PHARMACEUTICAL EXCIPIENTS
    Heinaemaeki, Jyrki
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 50 : E19 - E19
  • [2] Regulatory Procedures and Integrated Requirements for Early Phase Development of a Pharmaceutical Drug Product
    Gaurav
    Patil, Niraj Sandeep
    Ranjan, Animesh
    Singh, Dilpreet
    [J]. REVIEWS ON RECENT CLINICAL TRIALS, 2024, 19 (01) : 2 - 3
  • [3] Emerging role of nanocrystals in pharmaceutical applications: A review of regulatory aspects and drug development process
    Chary, Padakanti Sandeep
    Shaikh, Samia
    Bhavana, Valamla
    Rajana, Naveen
    Vasave, Ravindra
    Mehra, Neelesh Kumar
    [J]. APPLIED MATERIALS TODAY, 2024, 40
  • [4] International regulatory aspects of chemical and drug residues
    Schnick, RA
    [J]. FISH INSPECTION, QUALITY CONTROL AND HACCP: A GLOBAL FOCUS, 1997, : 186 - 194
  • [5] IMPORTANCE OF PHARMACEUTICAL LABORATORY COMPLIANCE WITH INTERNATIONAL STANDARD REQUIREMENTS IN RESPECT OF RAISING THEIR COMPETITIVENESS
    Bozanic, Vojislav N.
    Pavlovic, Katarina B.
    Milicevic, Vesna K.
    Ilic, Bojan J.
    [J]. HEMIJSKA INDUSTRIJA, 2009, 63 (05) : 437 - 443
  • [6] Pharmaceutical Cocrystals: Regulatory and Strategic Aspects, Design and Development
    Gadade, Dipak Dilip
    Pekamwar, Sanjay Sudhakar
    [J]. ADVANCED PHARMACEUTICAL BULLETIN, 2016, 6 (04) : 479 - 494
  • [7] Methodological and regulatory aspects of pharmaceutical development of biological products
    Kurkin, D. V.
    Morkovin, E. I.
    Bakulin, D. A.
    Zaborovsky, A. V.
    Makarenko, I. E.
    Drai, R. V.
    Solodovnikov, A. G.
    Petrov, V. I.
    Koryanova, K. N.
    Lycheva, N. A.
    Voskresensky, S. A.
    Strygin, A. V.
    Kolosov, Yu. A.
    Gorbunova, Yu. V.
    Ivanova, O. V.
    [J]. PHARMACY & PHARMACOLOGY-FARMATSIYA I FARMAKOLOGIYA, 2023, 11 (05): : 384 - 398
  • [8] Regulatory aspects of integration of pharmacogenetics into drug development
    Shah R.R.
    [J]. International Journal of Pharmaceutical Medicine, 2001, 15 (2) : 67 - 69
  • [9] Enantiomeric drug development: Issues, considerations, and regulatory requirements
    Srinivas, NR
    Barbhaiya, RH
    Midha, KK
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2001, 90 (09) : 1205 - 1215
  • [10] Safety and regulatory requirements and challenge for CNS drug development
    Gad, Shayne C.
    [J]. NEUROBIOLOGY OF DISEASE, 2014, 61 : 39 - 46
12345